Learn More
Allitinib tosylate, MedChemExpress
MedChemExpress Allitinib tosylate (AST-1306 (TsOH)) is an orally active and irreversible EGFR and ErbB2 inhibitor with IC50s of 0.5 and 3 nM, respectively. Allitinib tosylate also inhibits ErbB4 with an IC50 of 0.8 nM. Allitinib tosylate is an anilino-quinazoline compound and has anti-cancer activity
Brand: Medchem Express HY-13427

Description
Allitinib tosylate (AST-1306 (TsOH)) is an orally active and irreversible EGFR and ErbB2 inhibitor with IC50s of 0.5 and 3 nM, respectively. Allitinib tosylate also inhibits ErbB4 with an IC50 of 0.8 nM. Allitinib tosylate is an anilino-quinazoline compound and has anti-cancer activitySpecifications
Allitinib tosylate | |
Yellow | |
C31H26ClFN4O5S | |
AST-1306 (TsOH) | |
FC1=CC=CC(COC2=C(Cl)C=C(NC3=NC=NC4=C3C=C(NC(C=C)=O)C=C4)C=C2)=C1.O=S(C5=CC=C(C)C=C5)(O)=O | |
621.08 | |
Research | |
Cancer-Kinase/protease |
1050500-29-2 | |
Research | |
10 mg | |
DMSO : 50 mg/mL (80.50 mM; Need ultrasonic) | |
621.08 | |
99.46% | |
Solid |
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Research purposes only